BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18803476)

  • 1. Cancer screening: the clash of science and intuition.
    Kramer BS; Croswell JM
    Annu Rev Med; 2009; 60():125-37. PubMed ID: 18803476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The science of early detection.
    Kramer BS
    Urol Oncol; 2004; 22(4):344-7. PubMed ID: 15283894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cancer: evaluating the evidence.
    Gates TJ
    Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].
    Oshima A
    Gan No Rinsho; 1988 Oct; 34(12):1637-41. PubMed ID: 3193607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias in breast cancer research in the screening era.
    Cox B; Sneyd MJ
    Breast; 2013 Dec; 22(6):1041-5. PubMed ID: 23988397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screenings, diagnostic technology evolution, and cancer control.
    Stracci F
    Methods Mol Biol; 2009; 471():107-36. PubMed ID: 19109777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the efficacy of cancer screening.
    Jacklyn G; Bell K; Hayen A
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of cancer screening: lessons from history and study design issues.
    Croswell JM; Ransohoff DF; Kramer BS
    Semin Oncol; 2010 Jun; 37(3):202-15. PubMed ID: 20709205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efforts in fighting against cancer in Croatia have to be focused on the primary health care.
    Trtica LM; Strnad M; Gmajnić R; Ebling B; Ebling Z; Marković I; Samija M
    Coll Antropol; 2008 Sep; 32(3):709-24. PubMed ID: 18982742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.
    Kafadar K; Prorok PC
    Stat Med; 2009 Jul; 28(16):2116-46. PubMed ID: 19424959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cancer biology, lead time bias, and length bias in the debate about cancer screening tests.
    Kay BR; Witte DL
    J Insur Med; 1991; 23(2):102-4. PubMed ID: 10147769
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Cohort studies of the efficacy of screening for cancer.
    Weiss NS
    Epidemiology; 2015 May; 26(3):362-4. PubMed ID: 25764250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions for intuitive expertise: a failure to disagree.
    Kahneman D; Klein G
    Am Psychol; 2009 Sep; 64(6):515-26. PubMed ID: 19739881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 16. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dentification and correction of the lead-time bias and length bias in cancer screening studies].
    Yang Z; Zhou JC; Chen R; Wei WW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1183-1187. PubMed ID: 31683411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of timely information in national cancer screening programmes.
    Droljc A; Grbec T; Orel A
    Stud Health Technol Inform; 2009; 150():81-5. PubMed ID: 19745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The naïve intuitive statistician: a naïve sampling model of intuitive confidence intervals.
    Juslin P; Winman A; Hansson P
    Psychol Rev; 2007 Jul; 114(3):678-703. PubMed ID: 17638502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.